View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsCBD Global Sciences 過去の業績過去 基準チェック /06CBD Global Sciencesの収益は年間平均-4.3%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間23.4% 40.5%割合で 減少しています。主要情報-4.31%収益成長率19.99%EPS成長率Pharmaceuticals 業界の成長23.06%収益成長率-40.54%株主資本利益率n/aネット・マージン-1,253.65%前回の決算情報31 Mar 2022最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Apr 30Hempacco Co., Inc. (NasdaqCM:HPCO) entered into a non-binding letter of intent to acquire CBD Global Sciences Inc.Hempacco Co., Inc. (NasdaqCM:HPCO) entered into a non-binding letter of intent to acquire CBD Global Sciences Inc. on April 30, 2024. The combined company, to retain the name “Illumination Brands”. The parties have not yet finalized the terms of the potential business combination, a definitive combination agreement has not yet been entered into, and there is no guarantee that a definitive agreement will be entered into, or that the contemplated business combination will ever occur.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Jeff Hays was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 27CBD Global Sciences Inc. Announces Change of Chief Financial OfficerCBD Global Sciences Inc. announced that Mr. Alexander McAulay tendered his resignation as Chief Financial Officer (“CFO”) of the Company effective April 14, 2022. The Company also announced that Mr. Glenn Dooley has been appointed as the interim Chief Financial Officer of the Company effective April 14, 2022. Mr. Dooley is also a director and Chief Operating Officer of the Company. He was a co-founder of Strasburg Pharms, LLC, SMBT, LLC and CannaOil Inc., all wholly-owned subsidiaries of Global NV. He is also a co-founder/co-owner, broker and operations manager of MAC5 Mortgage Inc. which he founded with Brad Wyatt in 2006.お知らせ • Apr 06CBD Global Sciences Inc., Annual General Meeting, May 12, 2022CBD Global Sciences Inc., Annual General Meeting, May 12, 2022.お知らせ • Feb 17CBD Global Sciences, Inc. Announces the Successful Launch of Rap Snacks in the Colorado Market That Exceeded First Week Sales ExpectationsCBD Global Sciences Inc. announced the successful launch of Rap Snacks in the Colorado market that exceeded first week sales expectations. Within the first week of sales to the first few hundred of over 5000 stores in the Colorado and Wyoming markets the team sold through its first order of RAP SNACKS® and has placed additional and larger orders as demand for the tasty snack grows exponentially. Within the first couple of days into its soft launch store owners gobbled up all the inventory forcing a reorder of the product to continue to introduce Colorado and parts of Wyoming to Rap Snacks. Shortly after the launch of the snack product, the Oowee Lemonade made its way into the distribution channel with the same positive response for the new products.Board Change • Sep 28No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.お知らせ • Mar 17Legacy Distribution Group, a Subsidiary of CBD Global Sciences, to Begin Distribution for LIFEAID Beverage Co.(R)CBD Global Sciences Inc., shared that it is adding new brands to its distribution channel. Legacy Distribution Group, "Legacy Distribution" (Denver, CO) is one of the country's first CBD-only Direct Store Delivery (DSD) distributors. CBD Global's Legacy Distribution Group is excited to announce the addition of LIFEAID Beverage Co.(R) to its family of brands. Legacy will be carrying the LIFEAID Hemp line and expects it to be one of the most successful products in their portfolio.Is New 90 Day High Low • Feb 06New 90-day high: CA$0.34The company is up 15% from its price of CA$0.30 on 06 November 2020. The Canadian market is up 14% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Pharmaceuticals industry, which is up 70% over the same period.お知らせ • Jan 13Ed McCaffrey and CBD Global Sciences Sign A Two-Year Endorsement Agreement with Aethics(TM)CBD Global Sciences Inc. announced the finalization of an agreement with Ed McCaffrey, three-time Superbowl Champion and Pro Bowl Athlete, to endorse the Company's CBD infused sports wellness brand Aethics(TM). Ed McCaffrey, former NFL Athlete, has decided to endorse Aethics(TM), a CBD infused sports wellness product line that includes full spectrum tinctures, topicals, hydration and confectionary products. Ed was extremely pleased to find a CBD infused product line geared towards athletes that focuses on mitigating pain and other ailments for the human body in an all-natural way.お知らせ • Jan 09CBD Global Sciences, Inc. Announces to Launch of the New CBD Product Line Dog Unleashed CBDCBD Global Sciences Inc. announced the launch of the new CBD product line “Dog Unleashed CBD”. Dog the Bounty Hunter and CBD Global Sciences have partnered to create a new CBD brand called ‘Dog Unleashed CBD’ which has been rolled out with a robust line of CBD products aimed at addressing multiple ailments in the human body with a holistic approach. Initial sales of Dog Unleashed CBD can be found at www.dogunleashedcbd.com, an internet sales platform. The product launch is timed to coincide with his reality TV docudrama Dog Unleashed, that is airing on a subscription-based app and will be streaming online. The initial product line will offer 12 different SKUs focused on multi-flavored tinctures offered in three different strengths 1000MG, 2000MG and 3500MG. In addition to the tincture products, Dog will offer both lotions and salves and all 12 SKUs are infused with a full spectrum CBD oil that is lab tested for quality and accuracy. All products meet established state and federal requirements of no more than 0.3% delta-9-tetrahydrocannabinol and can be sold in all 50 states. The Company will expand the product offerings over the next two quarters in 2021 which will include CBD infused confectionary products and a hydration line to include multi flavored energy drinks.お知らせ • Dec 17Dog the Bounty Hunter Signs A Two-Year Partnership with CBD Global Sciences to Create and Sell ‘Dog Unleashed CBD’CBD Global Sciences Inc. announced the finalization of an agreement with Dog the Bounty Hunter to launch a CBD product line branded as ‘Dog Unleashed CBD’ which will coincide with his upcoming reality TV docudrama called ‘Dog Unleashed’ in Second Quarter of 2021.Dog the Bounty Hunter and CBD Global Sciences have partnered to create a new CBD brand called ‘Dog Unleashed CBD’ which will roll out First Quarter 2021 with a robust line of CBD products aimed at addressing multiple ailments in the human body using a holistic approach. Initial sales of Dog Unleashed CBD on internet sales platform is set to open by the end of this month. The product launch is timed to coincide with the fourth airing of his reality TV docudrama airing on a subscription-based app and streaming online. While testing the waters on viewership, Dog had over 30,000 new subscribers after just two Instagram postings about the new show. Viewership for the new docudrama is expected to beat all previous records.お知らせ • Oct 10CBD Global Sciences Launches Aethics Product Line on the First and Most Popular European Ecommerce CBD Market PlatformCBD Global Sciences Inc. announced the launch of its premier CBD product line Aethics on the first and most popular European eCommerce CBD market platform Mellow. The Company will be launching a selection of its most popular Aethics CBD products on the Mellow Store site. The products will be available on the site in the UK, and throughout many other EU countries. Mellow provides a turnkey solution for access to the European CBD marketplace including regulatory compliance and payment and shipping support. Mellows eCommerce CBD marketplace provides customers with the highest quality and reputable CBD brands and products. Products sold through their site are fully vetted by the company and must adhere to the highest level of quality control and industry testing.お知らせ • Oct 06+ 1 more updateCBD Global Sciences Inc. announced that it has received $0.7744 million in fundingOn September 29, 2020, CBD Global Sciences Inc. (CNSX:CBDN) closed the transaction.お知らせ • Sep 24CBD Global Sciences Aethics Product Line Receives Vendor Approval From Kroger StoresCBD Global Sciences Inc. announced that the Company has been approved as a CBD vendor with America's grocery retailer. The Kroger Company. The Kroger Company operates, under a variety of brand names, in 2,758 grocery retail locations throughout the U.S. and currently sells CBD products in 1,000+ stores nationwide. The global acceptance of CBD products is helping to broaden the distribution and availability of CBD Global Sciences' "Aethics" product line. The planned expansion by Kroger into additional product lines represents a great opportunity for CBD Global to showcase its Aethics products into approximately 22 states and 1,000+ stores across many of Kroger's retail banners, including Kroger, Dillions, Fry's, Fred Meyer, King Sooper, Pick `n Save, QFC and Smiths.お知らせ • Aug 07CBD Global Sciences Inc. Auditor Raises 'Going Concern' DoubtCBD Global Sciences Inc. filed its Annual on Jul 30, 2020 for the period ending Dec 31, 2019. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.お知らせ • Jun 20+ 1 more updateCBD Global Sciences Inc. announced that it has received $0.03 million in fundingOn June 19, 2020, CBD Global Sciences Inc. (CNSX:CBDN) closed the transaction. On the same date, the company has received $15,000 in its second tranche.収支内訳CBD Global Sciences の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史CNSX:CBDN 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費31 Mar 220-52031 Dec 210-53030 Sep 210-42030 Jun 210-93031 Mar 210-63031 Dec 200-52030 Sep 20-2-144030 Jun 200-154031 Mar 201-84031 Dec 192-94031 Jul 19000031 Dec 181-330質の高い収益: CBDNは現在利益が出ていません。利益率の向上: CBDNは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: CBDNは利益が出ておらず、過去 5 年間で損失は年間4.3%の割合で増加しています。成長の加速: CBDNの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: CBDNは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 64.6% ) と比較することは困難です。株主資本利益率高いROE: CBDNの負債は資産を上回っているため、自己資本利益率を計算することは困難です。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2022/10/08 20:32終値2022/07/11 00:00収益2022/03/31年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋CBD Global Sciences Inc. これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Apr 30Hempacco Co., Inc. (NasdaqCM:HPCO) entered into a non-binding letter of intent to acquire CBD Global Sciences Inc.Hempacco Co., Inc. (NasdaqCM:HPCO) entered into a non-binding letter of intent to acquire CBD Global Sciences Inc. on April 30, 2024. The combined company, to retain the name “Illumination Brands”. The parties have not yet finalized the terms of the potential business combination, a definitive combination agreement has not yet been entered into, and there is no guarantee that a definitive agreement will be entered into, or that the contemplated business combination will ever occur.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Jeff Hays was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 27CBD Global Sciences Inc. Announces Change of Chief Financial OfficerCBD Global Sciences Inc. announced that Mr. Alexander McAulay tendered his resignation as Chief Financial Officer (“CFO”) of the Company effective April 14, 2022. The Company also announced that Mr. Glenn Dooley has been appointed as the interim Chief Financial Officer of the Company effective April 14, 2022. Mr. Dooley is also a director and Chief Operating Officer of the Company. He was a co-founder of Strasburg Pharms, LLC, SMBT, LLC and CannaOil Inc., all wholly-owned subsidiaries of Global NV. He is also a co-founder/co-owner, broker and operations manager of MAC5 Mortgage Inc. which he founded with Brad Wyatt in 2006.
お知らせ • Apr 06CBD Global Sciences Inc., Annual General Meeting, May 12, 2022CBD Global Sciences Inc., Annual General Meeting, May 12, 2022.
お知らせ • Feb 17CBD Global Sciences, Inc. Announces the Successful Launch of Rap Snacks in the Colorado Market That Exceeded First Week Sales ExpectationsCBD Global Sciences Inc. announced the successful launch of Rap Snacks in the Colorado market that exceeded first week sales expectations. Within the first week of sales to the first few hundred of over 5000 stores in the Colorado and Wyoming markets the team sold through its first order of RAP SNACKS® and has placed additional and larger orders as demand for the tasty snack grows exponentially. Within the first couple of days into its soft launch store owners gobbled up all the inventory forcing a reorder of the product to continue to introduce Colorado and parts of Wyoming to Rap Snacks. Shortly after the launch of the snack product, the Oowee Lemonade made its way into the distribution channel with the same positive response for the new products.
Board Change • Sep 28No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
お知らせ • Mar 17Legacy Distribution Group, a Subsidiary of CBD Global Sciences, to Begin Distribution for LIFEAID Beverage Co.(R)CBD Global Sciences Inc., shared that it is adding new brands to its distribution channel. Legacy Distribution Group, "Legacy Distribution" (Denver, CO) is one of the country's first CBD-only Direct Store Delivery (DSD) distributors. CBD Global's Legacy Distribution Group is excited to announce the addition of LIFEAID Beverage Co.(R) to its family of brands. Legacy will be carrying the LIFEAID Hemp line and expects it to be one of the most successful products in their portfolio.
Is New 90 Day High Low • Feb 06New 90-day high: CA$0.34The company is up 15% from its price of CA$0.30 on 06 November 2020. The Canadian market is up 14% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Pharmaceuticals industry, which is up 70% over the same period.
お知らせ • Jan 13Ed McCaffrey and CBD Global Sciences Sign A Two-Year Endorsement Agreement with Aethics(TM)CBD Global Sciences Inc. announced the finalization of an agreement with Ed McCaffrey, three-time Superbowl Champion and Pro Bowl Athlete, to endorse the Company's CBD infused sports wellness brand Aethics(TM). Ed McCaffrey, former NFL Athlete, has decided to endorse Aethics(TM), a CBD infused sports wellness product line that includes full spectrum tinctures, topicals, hydration and confectionary products. Ed was extremely pleased to find a CBD infused product line geared towards athletes that focuses on mitigating pain and other ailments for the human body in an all-natural way.
お知らせ • Jan 09CBD Global Sciences, Inc. Announces to Launch of the New CBD Product Line Dog Unleashed CBDCBD Global Sciences Inc. announced the launch of the new CBD product line “Dog Unleashed CBD”. Dog the Bounty Hunter and CBD Global Sciences have partnered to create a new CBD brand called ‘Dog Unleashed CBD’ which has been rolled out with a robust line of CBD products aimed at addressing multiple ailments in the human body with a holistic approach. Initial sales of Dog Unleashed CBD can be found at www.dogunleashedcbd.com, an internet sales platform. The product launch is timed to coincide with his reality TV docudrama Dog Unleashed, that is airing on a subscription-based app and will be streaming online. The initial product line will offer 12 different SKUs focused on multi-flavored tinctures offered in three different strengths 1000MG, 2000MG and 3500MG. In addition to the tincture products, Dog will offer both lotions and salves and all 12 SKUs are infused with a full spectrum CBD oil that is lab tested for quality and accuracy. All products meet established state and federal requirements of no more than 0.3% delta-9-tetrahydrocannabinol and can be sold in all 50 states. The Company will expand the product offerings over the next two quarters in 2021 which will include CBD infused confectionary products and a hydration line to include multi flavored energy drinks.
お知らせ • Dec 17Dog the Bounty Hunter Signs A Two-Year Partnership with CBD Global Sciences to Create and Sell ‘Dog Unleashed CBD’CBD Global Sciences Inc. announced the finalization of an agreement with Dog the Bounty Hunter to launch a CBD product line branded as ‘Dog Unleashed CBD’ which will coincide with his upcoming reality TV docudrama called ‘Dog Unleashed’ in Second Quarter of 2021.Dog the Bounty Hunter and CBD Global Sciences have partnered to create a new CBD brand called ‘Dog Unleashed CBD’ which will roll out First Quarter 2021 with a robust line of CBD products aimed at addressing multiple ailments in the human body using a holistic approach. Initial sales of Dog Unleashed CBD on internet sales platform is set to open by the end of this month. The product launch is timed to coincide with the fourth airing of his reality TV docudrama airing on a subscription-based app and streaming online. While testing the waters on viewership, Dog had over 30,000 new subscribers after just two Instagram postings about the new show. Viewership for the new docudrama is expected to beat all previous records.
お知らせ • Oct 10CBD Global Sciences Launches Aethics Product Line on the First and Most Popular European Ecommerce CBD Market PlatformCBD Global Sciences Inc. announced the launch of its premier CBD product line Aethics on the first and most popular European eCommerce CBD market platform Mellow. The Company will be launching a selection of its most popular Aethics CBD products on the Mellow Store site. The products will be available on the site in the UK, and throughout many other EU countries. Mellow provides a turnkey solution for access to the European CBD marketplace including regulatory compliance and payment and shipping support. Mellows eCommerce CBD marketplace provides customers with the highest quality and reputable CBD brands and products. Products sold through their site are fully vetted by the company and must adhere to the highest level of quality control and industry testing.
お知らせ • Oct 06+ 1 more updateCBD Global Sciences Inc. announced that it has received $0.7744 million in fundingOn September 29, 2020, CBD Global Sciences Inc. (CNSX:CBDN) closed the transaction.
お知らせ • Sep 24CBD Global Sciences Aethics Product Line Receives Vendor Approval From Kroger StoresCBD Global Sciences Inc. announced that the Company has been approved as a CBD vendor with America's grocery retailer. The Kroger Company. The Kroger Company operates, under a variety of brand names, in 2,758 grocery retail locations throughout the U.S. and currently sells CBD products in 1,000+ stores nationwide. The global acceptance of CBD products is helping to broaden the distribution and availability of CBD Global Sciences' "Aethics" product line. The planned expansion by Kroger into additional product lines represents a great opportunity for CBD Global to showcase its Aethics products into approximately 22 states and 1,000+ stores across many of Kroger's retail banners, including Kroger, Dillions, Fry's, Fred Meyer, King Sooper, Pick `n Save, QFC and Smiths.
お知らせ • Aug 07CBD Global Sciences Inc. Auditor Raises 'Going Concern' DoubtCBD Global Sciences Inc. filed its Annual on Jul 30, 2020 for the period ending Dec 31, 2019. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
お知らせ • Jun 20+ 1 more updateCBD Global Sciences Inc. announced that it has received $0.03 million in fundingOn June 19, 2020, CBD Global Sciences Inc. (CNSX:CBDN) closed the transaction. On the same date, the company has received $15,000 in its second tranche.